- Home
- AIZ vs CORT Comparison
AIZ vs CORT Comparison
Compare AIZ & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- CORT
- Stock Information
- Founded
- AIZ 1892
- CORT 1998
- Country
- AIZ United States
- CORT United States
- Employees
- AIZ N/A
- CORT N/A
- Industry
- AIZ Property-Casualty Insurers
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- AIZ Finance
- CORT Health Care
- Exchange
- AIZ Nasdaq
- CORT Nasdaq
- Market Cap
- AIZ 10.9B
- CORT 8.8B
- IPO Year
- AIZ N/A
- CORT N/A
- Fundamental
- Price
- AIZ $219.23
- CORT $88.63
- Analyst Decision
- AIZ Strong Buy
- CORT Strong Buy
- Analyst Count
- AIZ 7
- CORT 4
- Target Price
- AIZ $235.86
- CORT $139.00
- AVG Volume (30 Days)
- AIZ 318.2K
- CORT 917.9K
- Earning Date
- AIZ 11-04-2025
- CORT 10-29-2025
- Dividend Yield
- AIZ 1.48%
- CORT N/A
- EPS Growth
- AIZ N/A
- CORT N/A
- EPS
- AIZ 13.78
- CORT 1.11
- Revenue
- AIZ $12,304,900,000.00
- CORT $716,080,000.00
- Revenue This Year
- AIZ $7.85
- CORT $30.77
- Revenue Next Year
- AIZ $4.82
- CORT $37.75
- P/E Ratio
- AIZ $15.74
- CORT $81.04
- Revenue Growth
- AIZ 6.42
- CORT 25.71
- 52 Week Low
- AIZ $174.97
- CORT $42.01
- 52 Week High
- AIZ $230.55
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- AIZ 58.06
- CORT 77.61
- Support Level
- AIZ $213.21
- CORT $82.70
- Resistance Level
- AIZ $223.65
- CORT $90.71
- Average True Range (ATR)
- AIZ 3.48
- CORT 2.28
- MACD
- AIZ 0.25
- CORT 0.72
- Stochastic Oscillator
- AIZ 66.18
- CORT 96.01
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.